Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech HBANL Q1 2026 Earnings Preferred Shares Edge Up Despite Significant EPS Miss WBD Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress in Turnaround FMS Q1 2026 Earnings EPS Miss Amidst Operational Headwinds Gladstone Land Corporation LANDP Q1 2026 Earnings Preferred Shares Beat Estimates Despite Negative EPS SBLK Q1 2026 Earnings Strong Beat on EPS as Dry Bulk Market Improves